APASL Oncology 2022 (APASL STC in Takamatsu).
Awardees
The Organizing Committee recognizes the excellence of the papers in the presentation for The Asian Pacific Association for the Study of the Liver Oncology 2022 Takamatsu held on September 1-3, 2022 in Takamatsu Japan (Hybrid Meeting). Congratulations!!
Presidential Award
Investigator Award
Information of Awards
The excellent papers will be awarded (for both overseas/domestic, both online/on-site attendees)
| Presidential Award: | JPY 50,000 |
|---|---|
| Investigator Award: | JPY 10,000 |
- For On-site attendees, Travel Award will be awarded to the excellent presenters.
| Travel Award-Overseas (for overseas attendees who attend on-site): | JPY 100,000 |
|---|---|
| Trave Award-Domestic (for domestic attendees who attend on-site): | JPY 50,000 |
（There are no Travel Award options on the form. It will be selected by the organizing committee.）
Call for Abstract
Abstract Submission
Abstract Submission has been closed. Thank you for the large number of submission!
Please go to the Online Abstract Submission Form by clicking below.
If you have already submitted your abstract, and would like to view, edit or delete the abstract, please go to the View/Edit/Delete page by clicking below.
(Submission No. and Password are required to enter the page.)
Conditions for Submission Abstract for APASL Oncology 2022 in Takamatsu
- The Scientific Committee of APASL Oncology 2022 in Takamatsu will only accept original scientific material, which has not been published before. However, abstracts presented at local, regional or national meetings may be submitted.
- Abstracts should be submitted in English.
- The abstract is requested to start with the Background, continue with the Methods, Results, and finalized with the Conclusions.
- The abstract must not exceed 250 words.
- The category (one or two) defining the abstract must be chosen and marked on the form.
- Preferred type of the presentation (oral, poster) must be marked on the form.
- If there is any graphs, tables/statics or pictures, please send them to the congress secretariat info@apaslstc-takamatsu2022.org attached by jpg file, with your email subject as "figures for submission No. xxx (your submission no.)" after abstract online-submission has been completed.
- Maximum size of any images is 1024 x 768 pixels.
- Case report is acceptable.
- The presenting author is required to complete conference pre-registration.
Categories
Clinical Research of Hepatocellular Carcinoma (HCC)
| Epidemiology of HCC in Asia |
| Biomarker and Diagnosis of HCC |
| Imaging of HCC |
| Treatment for Early-Stage HCC |
| Treatment for Intermediate-Stage HCC |
| Treatment for Advanced HCC |
| Surgical Treatment |
| Liver Transplantation |
| Radiotherapy |
| Interventional Radiology (IVR) |
| Radiofrequency Ablation (RFA)/ Microwave Coagulo-necrotic Therapy (MCN) |
| Immuno-Oncotherapy/ Molecularly Targeted Drugs |
| Prevention of HCC Occurrence and Recurrence |
| Pathology |
| HCC and Other Organs |
| Portal Hypertension |
| Cirrhosis and Complications |
| Nutrient Metabolism / Trace Elements |
| Case Report(s) and Miscellaneous |
| HCC and Viral Hepatitis - Clinical |
| HCC and Other Infection in Liver Disease- Clinical |
| HCC and Nonalcoholic Fatty Liver Disease - Clinical |
| HCC and Alcoholic Liver Disease- Clinical |
| HCC and Autoimmune / Cholestatic Disease- Clinical |
| HCC and Fibrosis / Cirrhosis - Clinical |
| HCC and Metabolic / Genetic Disease- Clinical |
Basic Research of Hepatocellular Carcinoma (HCC)
| HCC and Hepatitis B - Basic |
| HCC and Hepatitis C - Basic |
| HCC and Other Infection in Liver Disease- Basic |
| HCC and Nonalcoholic Fatty Liver Disease - Basic |
| HCC and Alcoholic Liver Disease- Basic |
| HCC and Autoimmune / Cholestatic Disease- Basic |
| HCC and Fibrosis / Cirrhosis- Basic |
| HCC and Metabolic / Genetic Disease- Basic |
| HCC and Genome Sciences- Basic |
| HCC and MicroRNA- Basic |
Cholangiocellular Cancer (CCC)
| Basic Research |
| Clinical Research |
Metastatic Liver Cance
| Basic Research |
| Clinical Research |
Other Hepatobiliary Neoplasia
| Basic Research |
| Clinical Research |
CopyrightAPASL Oncology 2022 (APASL STC in Takamatsu).